XWELL, Inc. (XWEL)
NASDAQ: XWEL · Real-Time Price · USD
1.745
-0.045 (-2.50%)
Nov 4, 2024, 4:00 PM EST - Market closed
XWELL Employees
As of December 31, 2023, XWELL had 337 total employees, including 266 full-time and 71 part-time employees. The number of employees decreased by 146 or -30.23% compared to the previous year.
Employees
337
Change (1Y)
-146
Growth (1Y)
-30.23%
Revenue / Employee
$97,564
Profits / Employee
-$62,344
Market Cap
9.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
NKGen Biotech | 63 |
Addex Therapeutics | 23 |
Virax Biolabs Group | 17 |
Soligenix | 15 |
Ensysce Biosciences | 7 |
GlucoTrack | 6 |
XWEL News
- 7 weeks ago - ThredUp And 2 Other Stocks Under $2 Executives Are Buying - Benzinga
- 2 months ago - XWELL Appoints Ezra Ernst as New President and Chief Executive Officer - GlobeNewsWire
- 2 months ago - XWELL Announces Partnership with Priority Pass - GlobeNewsWire
- 2 months ago - XWELL, Inc. Adopts Tax Benefits Preservation Plan - GlobeNewsWire
- 2 months ago - XWELL, Inc. Reports Second Quarter 2024 Results - GlobeNewsWire
- 2 months ago - XWELL Comments on CPC's Withdrawal of Threatened Proxy Fight and Related Lawsuit - GlobeNewsWire
- 3 months ago - XWELL Announces Closing of $1.4 Million Registered Direct Offering Priced At Premium to Market - GlobeNewsWire
- 3 months ago - CPC Issues Letter to Fellow XWELL, Inc. Shareholders Revealing Intention Behind Recent Schedule 13D Filing & Lawsuit Against Entrenched Board of Directors - GlobeNewsWire